AERG Insider Sale: Donaghey Sells 10,000 Shares; Holds 2.35M Options and 100k RSUs
Rhea-AI Filing Summary
Christopher W. Donaghey, President & CEO and Director of Applied Energetics, Inc. (AERG), reported a sale of 10,000 shares of common stock on 09/25/2025 at a weighted average price of $2.00 per share (trades ranged $1.95–$2.05), leaving him with 173,592 shares beneficially owned. The filing discloses substantial derivative holdings: 1,000,000 incentive stock options at $0.78 (subject to revenue-based vesting milestones), 1,000,000 incentive options at $2.36 (vesting over four years, 750,000 vested), 200,000 non-statutory options at $0.61, 150,000 non-statutory options at $0.35 (vested by schedule), and 100,000 restricted stock units vesting annually starting July 12, 2023.
Positive
- Retention of significant equity incentives: reporting person holds large option grants (totaling 2,350,000 options) and 100,000 RSUs indicating alignment with shareholder interests
- Performance alignment: 1,000,000 incentive options include revenue-based vesting milestones, tying compensation to company revenue goals
Negative
- Insider disposition: sale of 10,000 common shares on 09/25/2025 at a weighted average price of approximately $2.00 reduced direct holdings to 173,592 shares
Insights
TL;DR: Insider sale disclosed; officer retains significant option and RSU holdings with milestone and time-based vesting.
The Form 4 documents a routine disposition of 10,000 common shares by the CEO/Director at market prices on 09/25/2025. While the sale reduces his direct common stock holdings to 173,592 shares, the reporting person continues to hold substantial equity-linked compensation across multiple option grants totaling 2,350,000 option shares and 100,000 RSUs. Several grants include performance-based vesting tied to revenue milestones, which may align executive incentives with company growth targets.
TL;DR: Transaction is a disclosed insider sale; material compensation detail shows mix of time- and performance-vested awards.
The filing provides clear exercise prices and vesting terms: incentive options at $0.78 carry revenue-triggered vesting across tranches; a $2.36 grant vests over four years with 750,000 currently vested; other NSOs have completed or scheduled vesting. The RSUs have annual vesting and no expiration. These details are relevant for modeling potential future dilution and executive retention cost but contain no forward-looking projections in this filing.